Back to Search
Start Over
Research Conducted at Mayo Clinic Has Provided New Information about Central Nervous System Agents (Should Rocuronium and Sugammadex Replace Succinylcholine for Airway Emergencies In Class B Ambulatory Anesthesia Settings?).
- Source :
- Pain & Central Nervous System Week; 5/12/2023, p1332-1332, 1p
- Publication Year :
- 2023
-
Abstract
- According to the news reporters, the research concluded: "Both succinylcholine and rocuronium-sugammadex provide adequate treatment of airway emergencies and rapid return of spontaneous ventilation, but succinylcholine has a superior economic and clinical profile." Keywords: Jacksonville; State:Florida; United States; North and Central America; Amines; Anesthesia; Central Nervous System Agents; Choline; Dicarboxylic Acids; Drugs and Therapies; Organic Chemicals; Pain Medicine; Pharmaceuticals; Quaternary Ammonium Compounds; Succinates; Succinic Acid; Succinylcholine; Sugammadex Therapy; Trimethyl Ammonium Compounds EN Jacksonville State:Florida United States North and Central America Amines Anesthesia Central Nervous System Agents Choline Dicarboxylic Acids Drugs and Therapies Organic Chemicals Pain Medicine Pharmaceuticals Quaternary Ammonium Compounds Succinates Succinic Acid Succinylcholine Sugammadex Therapy Trimethyl Ammonium Compounds 1332 1332 1 05/08/23 20230512 NES 230512 2023 MAY 12 (NewsRx) -- By a News Reporter-Staff News Editor at Pain & Central Nervous System Week -- Investigators publish new report on Drugs and Therapies - Central Nervous System Agents. [Extracted from the article]
Details
- Language :
- English
- ISSN :
- 15316394
- Database :
- Supplemental Index
- Journal :
- Pain & Central Nervous System Week
- Publication Type :
- Periodical
- Accession number :
- 163531180